.nbspNovel alkali-tolerant rProtein A ligand withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH..nbspReduces the risk of product contamination and carryover.nbspImproves performance and reduces overall costs.nbspHigh dynamic binding capacity (DBC) for high titer cultures reduces process time and amount of medium used.nbspGeneric elution profile for different monoclonal antibodies enables platform approach to purification.nbspHigh-flow agarose matrix allows the processing of large feed volumes